Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...

The biotech company, which makes the Spikevax RNA-based Covid-19 vaccine, reported net income of $13 million, or 3 cents a share, compared with a loss of $3.6 billion, or $9.53 a share, in the same ...

Moderna Chief Human Resources Officer Tracey Franklin has expanded her role to Chief People and Digital Technology Officer, overseeing the Company's talent and digital functions. Brad Miller, Chief ...

Moderna Inc. said Thursday that it has entered into an agreement to buy the properties it currently leases in Norwood.

With the ability to capture more than twice its own weight in carbon, purported insulation, moisture- and fire-proof ...

A suicide bomber blew himself up at a train station in restive southwestern Pakistan on Saturday, killing at least 24 people, ...

Health Canada approves Moderna's mRNA RSV vaccine, company says Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age ... Ottawa mayor defends ...

Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms ...

Respiratory syncytial virus and influenza activity are on the rise in parts of the country, particularly among young children, according to the CDC's latest respiratory virus updates. Overall, the ...

as the presentation is indistinguishable from other respiratory tract infections, and epidemics often overlap. The microbiologic confirmation of RSV infection is based on detecting the virus in a ...